DERMASTRAT Trademark

Pharmaceutical preparations for the treatment of psoriasis, and pharmaceutical substances, namely, for the prediction of response to anti-Tumor Necrosis Factor, also known as TNF, therapies and sanitary preparations for the prediction of response to anti-Tumor Necrosis Factor therapies; diagnostic preparations and substances for medical use; diagnostic kits consisting primarily of multiplex polymerase chain reaction reagents and biochip array reagents; clinical diagnostic preparations for medical use; clinical diagnostic reagents for medical in vitro and/or vivo use; diagnostic scanning agents for in-vivo use used for the prediction of response to anti-Tumor Necrosis Factor therapies; diagnostic testing materials, namely, diagnostic preparations, reagents and contrast media for medical use; clinical medical reagents; reagents for use in diagnostic tests for medical purposes; reagents for use with analyzers for medical purposes; parts and fittings for all the aforesaid goods, namely, multiplex polymerase chain reaction reagents and biochip array reagents; chemical reagents for medical purposes; enzymes for medical purposes

Chemicals used in industry, science, photography, agriculture, horticulture and forestry; chemical reagents other than for medical purpose; enzymes for scientific and research purposes and proteins for industrial use; diagnostic preparations for scientific purposes; clinical diagnostic preparations or reagents other than for medical use; diagnostic preparations, namely, diagnostic scanning agents; diagnostic testing materials, namely, diagnostic preparations, reagents and contrast media other than for medical use; chemical reagents for use in diagnostic tests, other than for medical use; clinical diagnostic reagents for laboratory in vitro and/or vivo use

Medical services; providing health advice and information services; medical care services; health clinic services; healthcare services, namely, geriatric health care, physical therapy; medical health assessment services, namely, providing prediction of response to anti-Tumor Necrosis Factor therapies; diagnostic health screening services in the field of psoriasis; medical testing for prediction of response to therapy; medical diagnostic testing services; genetic testing for medical for medical purposes; medical clinics; advice, information and consultancy services for all of the aforesaid services

Scientific and technological services, namely, research and design in the field of psoriasis; medical research services; clinical research services, namely, conducting clinical trials for others; biological research; conducting clinical trials for others, namely, analysis, management and reporting of clinical data; consulting services in the field of quality assessment services for clinical laboratories; chemical research; chemical laboratory services; chemical analysis; scientific and medical laboratory services for analytical testing; medical laboratory services; biochemistry research and consultant advisory services; conducting clinical trials for others; providing computer aided diagnostic testing services for predicting response to anti-Tumor Necrosis Factor therapies for others in the field of science and research related thereto; scientific and technological services, namely, development of test equipment for medical apparatus for others; advice, information and consultancy services relating to all the aforesaid services